Should New MPN Medicines Be Covered by Insurance and Government Programs?

Published on

It's a hopeful time for MPN patients: Many new medicines are coming out that appear to be very effective, perhaps even more effective if used in combination. However, some government and insurance programs have balked at the cost, stating that these treatments only improve quality of life. But leading expert Dr. Ruben Mesa, from the Mayo Clinic, believes these groups are not seeing the true impact of the newest medicines. Watch as he shares his strong case, which advocates that new MPN medicines should be paid for by insurance and government plans. 

View more programs featuring

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on January 26, 2016